Research programme: metabolic disorders therapeutics - LG Life Sciences

Drug Profile

Research programme: metabolic disorders therapeutics - LG Life Sciences

Alternative Names: Cell protectant; GK Activator

Latest Information Update: 22 Oct 2014

Price : $50

At a glance

  • Originator LG Life Sciences
  • Class
  • Mechanism of Action Cell modulators; Glucokinase stimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity Yes

Highest Development Phases

  • Research Metabolic disorders; Type 2 diabetes mellitus

Most Recent Events

  • 22 Oct 2014 Early research is ongoing in South Korea
  • 20 Jul 2012 Early research in Metabolic disorders in South Korea (unspecified route)
  • 20 Jul 2012 Early research in Type-2 diabetes mellitus in South Korea (unspecified route)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top